Hundreds of millions of people are affected by viral hepatitis and metabolic liver diseases worldwide, which is taking a devastating toll on healthcare systems and the well-being of patients. More importantly, this trend is expected to rise in the next decade. What are the burdens and risks that liver diseases pose to patients? Which strategies would help prevent, screen, diagnose and treat these conditions? When can therapy be discontinued safely? Which strategies can be implemented to improve patients’ health? What are the success stories, challenges, and lessons learned in hepatitis elimination? What is the impact of underlying chronic liver disease on COVID-19 outcomes? Subscribe to the state-of-the-art hepatitis podcast to learn more about the most relevant topics regarding viral hepatitis.
